topbanner4 stretched.png
Rectangle 178.png

Creating Next Generation Digitized Cancer Treatments

We are a Swedish digital health company that improves the lives of cancer patients by enhancing and supporting treatments with our innovative Digital Therapeutics (DTx) platform. We are pioneering digital therapeutics in the field of Oncology and Specialized Healthcare.

Values With Our Digital Therapeutics

Our DTx platform SciMedOne allows a close interaction between the patient and the healthcare team, including a systematic analysis of real-world facts relating to the treatment given. All centered around the patient’s experience and challenges, aiming to improve disease management in all aspects on an individual basis.

SciMedOne empowers patients, healthcare providers and payers with digital tools for addressing a wide range of cancer diseases through high quality, safe, and effective data-driven digital interventions.


Treatment Outcomes

  • Improved adherence, efficiency, and safety

  • Optimized and personalized treatment

  • Earlier symptom detection


Treatment Costs

  • Improved utilization of resources

  • Improved patient self-management

  • Less need for emergency medical care


Real World Data

  • Improved and safer therapies and drugs

  • Reimbursement and pricing decisions

  • Quality registers

Oncology Care

Our DTx platform SciMedOne enables cancer care teams to manage, prioritize, and structure their follow-up of patients in a cost and time efficient way.


The patient has their own app, as a support and companion, that helps the individual to self-manage their health and keep in close contact with the health care team. 


The patient also reports symptoms and health related data that gives the cancer care team valuable complementary information for better and faster decision making. This can include changes in drug prescription and dosage, scheduling of an earlier re-visit, and treatment changes.

How It Works

Cancer care team


Doctor or nurse prescribes a DTx app to patient and registers patient in SciMedOne platform

Patient downloads and onboards the DTx app

Patient registers continuously symptoms, medication intake, and health related data with engaging and supportive DTx app

Cancer care team works proactively and efficiently with patients and prioritize critical cases with SciMedOne platform that uses smart algorithms and real-time data

Key Features


for optimal individualized results
  • Supports the patient journey

  • Focus on user experience and usability

  • Holistic 360-degree view on patient interventions

Disease Specific

for optimal therapy support
  • Pre-defined disease and treatment configurations

  • Adaptations for personalized therapies

Smart Algorithms

for improved patient management
  • Automated patient feedback loops

  • Support for patient prioritization management

  • Continuously improved based on real data and user feedback

Compliant and Secure

for regulatory complicance fullfilment
  • CE marked as medical device

  • GDPR compliant

  • Secure data management

Modern and Flexible

for future proof implementation
  • Modern and scalable cloud-based architecture

  • Integration with electronic health record systems and healthcare information systems

What the Patients Say

"I experience the use of the app positively. It is easy to use and contributes to a clear summary of my state of health and mood."


- Breast cancer patient

“I am very happy with the app! I especially appreciate getting the lab test results directly in my smartphone.”


- Blood cancer patient

"The possibility to check that I am taking my medication as I should is important! It happens that I miss it some day, then a reminder is worth its weight in gold."


- Breast cancer patient

Specialized Healthcare

We develop and evaluate together with leading medical research universities and healthcare providers digital therapeutics supporting various lifestyle interventions and prevention of diseases.


Examples of digital interventions include increased physical activity, smoking cessation, healthy diet, and engaging in self-care activities. Our DTx platform is used to achieve better health in such various areas as stroke prevention and obesity.


We also utilize the knowledge and clinical evidence from this field for further development and refinement of our digital therapeutics within oncology and hematology.

ScientificMed in Numbers


Clinicals trials

Number of ongoing or completed randomized controlled trials (RCTs) where our digital therapeutics have been evaluated


Hospitals and clinics

Number of hospitals and clinics in the Nordics where our digital therapeutics have been evaluated or implemented


Pharmaceutical companies

Number of collaborations with top-tier pharmaceutical companies


© 2020 by ScientificMed Tech AB

ScientificMed Tech AB

Surbrunnsgatan 44A

SE-113 48 Stockholm, Sweden